Lafayette Investments’s Novo Nordisk NVO Stock Holding History

Lafayette Investments’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.52M	Buy	73,499 +1,044	+1%	+$44.9K	0.65%	36
2026 Q1	$2.66M	Buy	72,455 +3,317	+5%	+$157K	0.54%	47
2025 Q4	$3.52M	Buy	69,138 +293	+0.4%	+$15K	0.66%	39
2025 Q3	$3.82M	Buy	68,845 +21,091	+44%	+$1.23M	0.73%	39
2025 Q2	$3.3M	Buy	47,754 +40,725	+579%	+$2.77M	0.67%	43
2025 Q1	$488K	Buy	7,029 +1,083	+18%	+$89.4K	0.1%	93
2024 Q4	$511K	Buy	5,946 +1,946	+49%	+$210K	0.11%	86
2024 Q3	$476K	Hold	4,000	–	–	0.1%	90
2024 Q2	$571K	Hold	4,000	–	–	0.13%	80
2024 Q1	$514K	Hold	4,000	–	–	0.12%	82
2023 Q4	$414K	Sell	4,000 -1,000	-20%	-$98.9K	0.1%	91
2023 Q3	$455K	Hold	5,000	–	–	0.12%	85
2023 Q2	$405K	Hold	5,000	–	–	0.11%	87
2023 Q1	$398K	Hold	5,000	–	–	0.11%	88
2022 Q4	$338K	Hold	5,000	–	–	0.1%	92
2022 Q3	$249K	Hold	5,000	–	–	0.08%	103
2022 Q2	$279K	Hold	5,000	–	–	0.08%	99
2022 Q1	$278K	Hold	5,000	–	–	0.07%	105
2021 Q4	$280K	Hold	5,000	–	–	0.07%	106
2021 Q3	$240K	Hold	5,000	–	–	0.07%	109
2021 Q2	$209K	Buy	+5,000	New	+$194K	0.06%	118

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Lafayette Investments's NVO Position: Q2 2026 in Review

Lafayette Investments increased its Novo Nordisk (NVO) stake by 1.4% in Q2 2026, buying an estimated $44.9K and bringing the position to 73,499 shares worth $3.52M. The position accounts for 0.65% of the portfolio, ranked #36.

Lafayette Investments first reported a position in NVO in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.82M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Lafayette Investments held 73,499 shares of Novo Nordisk worth $3.52M as of Q2 2026.
Lafayette Investments bought 1,044 Novo Nordisk shares in Q2 2026, an estimated $44.9K.
Novo Nordisk made up 0.65% of Lafayette Investments's portfolio in Q2 2026, its #36 holding.
Lafayette Investments first reported a position in Novo Nordisk in Q2 2021 and has held it in 21 quarters since.
Lafayette Investments's Novo Nordisk position peaked at $3.82M in Q3 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Lafayette Investments's 13F filing for Q2 2026, filed 11 Aug 2026.